-

Retractable Technologies, Inc. to Host Virtual Annual Meeting of Shareholders

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) (the “Company”) today announced that, due to the public health impact of the coronavirus (COVID-19) pandemic, and related health and travel concerns, the adjourned 2020 annual meeting of shareholders of Retractable Technologies, Inc. (the “Annual Meeting”) has been changed to a virtual-only format via live webcast. As previously announced, the Annual Meeting will be held on June 22, 2020 at 10:00 a.m. Central time. Shareholders will not be able to attend the Annual Meeting in person.

Shareholders are entitled to participate in the live webcast of the Annual Meeting if they held shares of the Company as of the close of business on March 13, 2020, the record date. Such shareholders will be able to participate by visiting www.virtualshareholdermeeting.com/RVP2020 and entering the 16-digit control number found on the voting form that was enclosed with the previously-distributed proxy materials for the Annual Meeting. Online access will open shortly prior to the start of the Annual Meeting to allow time to log in.

A notice regarding the change to the format of the Annual Meeting (the “Notice”) is being filed with the Securities and Exchange Commission together with this press release.

About Retractable Technologies, Inc.

The Company manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe® syringes are uniquely designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. The EasyPoint® is a retractable needle that can be used with luer lock syringes, luer slip syringes, and prefilled syringes to give injections. The EasyPoint® needle also can be used to aspirate fluids and for blood collection. The Company’s products are distributed by various specialty and general line distributors.

For more information on Retractable Technologies, Inc., visit its website at www.retractable.com.

Contacts

Retractable Technologies, Inc.
John W. Fort III, 888-806-2626 or 972-294-1010
Vice President and Chief Financial Officer

Industry:

Retractable Technologies, Inc.

NYSEAM:RVP
Release Versions
English

Contacts

Retractable Technologies, Inc.
John W. Fort III, 888-806-2626 or 972-294-1010
Vice President and Chief Financial Officer

More News From Retractable Technologies, Inc.

Retractable Technologies, Inc. Announces Workforce Reduction

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports that it has reduced its workforce by approximately 16%. The reduction is expected to save an estimated $2.2 million in annual wages and employment benefits, or approximately 13% of total estimated workforce costs. The expected savings are offset by estimated one-time separation payments of approximately $122 thousand to the affected workers. Approximately 58% of the targeted payroll reduction affects...

Retractable Technologies, Inc. Reports Results for 2025

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports the following information relating to the year ended December 31, 2025. Further details concerning the results of operations as well as other matters are available in Retractable’s Form 10-K filed on March 27, 2026 with the U.S. Securities and Exchange Commission. The Company’s revenues for 2025 increased 15.8%. The Company’s revenues were approximately $38.3 million in 2025 as compared to approximat...

Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (“Retractable”) (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning January 1, 2026 through March 31, 2026. The dividends will be paid on April 20, 2026 to...
Back to Newsroom